# Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients

> **NCT00413920** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 222 (actual)

## Conditions studied

- Renal Transplantation

## Interventions

- **DRUG:** Enteric-coated mycophenolate sodium (EC-MPS)
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT00413920
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-03
- **Final completion:** —
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2011-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00413920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00413920, "Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00413920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*